These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


85 related items for PubMed ID: 938610

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Leukocyte migration inhibition assay in patients with bladder cancer.
    Schellhammer PF, Wright GL, Rosato FE, Faulconer RJ.
    J Urol; 1979 Dec; 122(6):746-9. PubMed ID: 513216
    [Abstract] [Full Text] [Related]

  • 3. Transitional cell carcinoma of the bladder. Differences between primary tumour and following relapses.
    Pizza G, Viza D, Fini M, Cuzzocrea D, Menniti D, Corrado F.
    Eur Urol; 1980 Dec; 6(1):45-7. PubMed ID: 7353578
    [Abstract] [Full Text] [Related]

  • 4. Leukocyte migration inhibition in vitro in bladder carcinoma.
    Lavergne JA, Lamm DL, Radwin HM, Harrington JT.
    Cancer Res; 1979 Jun; 39(6 Pt 1):1985-8. PubMed ID: 445398
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Production of a dialysable transfer factor of cell mediated immunity by lymphoblastoid cells in continuous proliferation].
    Goust JM, Viza D, Moulias R, Trejdosiewicz L, Lesourd B, Marescot MR, Prévot A.
    C R Acad Hebd Seances Acad Sci D; 1975 Jan 20; 280(3):371-4. PubMed ID: 808340
    [Abstract] [Full Text] [Related]

  • 8. Some uses and limitations of immunologic testing in human patients.
    Lavergne JA.
    Bol Asoc Med P R; 1981 Apr 20; 73(4):141-5. PubMed ID: 6946780
    [No Abstract] [Full Text] [Related]

  • 9. Transitional cell carcinoma: circulating tumor antigen correlated with presence/absence of tumor (leukocyte migration assay).
    Bowen JG.
    Natl Cancer Inst Monogr; 1978 Dec 20; (49):245-7. PubMed ID: 748778
    [Abstract] [Full Text] [Related]

  • 10. Identification of a methylation hotspot in the death receptor Fas/CD95 in bladder cancer.
    Watson CJ, O'Kane H, Maxwell P, Sharaf O, Petak I, Hyland PL, O'Rouke D, McKnight J, Canning P, Williamson K.
    Int J Oncol; 2012 Mar 20; 40(3):645-54. PubMed ID: 22076446
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunologic evaluation of human bladder cancer: in vitro studies.
    Elhilali MM, Nayak SK.
    Cancer; 1975 Feb 20; 35(2):419-31. PubMed ID: 1111918
    [Abstract] [Full Text] [Related]

  • 13. Mixed leukocyte culture reactivity of lymph node cells regional to transitional cell carcinoma of the bladder.
    Herr HW, Bean MA, Whitmore WF.
    Natl Cancer Inst Monogr; 1978 Dec 20; (49):177-81. PubMed ID: 155221
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lymphocyte response to transitional cell carcinoma: peripheral cytotoxicity and local tumor infiltration.
    Jones LW, O'Toole C.
    J Urol; 1977 Dec 20; 118(6):974-7. PubMed ID: 926279
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma.
    Hakala TR, Lange PH, Castro AE, Elliott AY, Fraley EE.
    J Urol; 1975 May 20; 113(5):663-7. PubMed ID: 1168732
    [Abstract] [Full Text] [Related]

  • 18. In vitro immune parameters in relation to clinical course in transitional cell carcinoma.
    Cummings KB, Kodera Y, Bean MA.
    Natl Cancer Inst Monogr; 1978 Dec 20; (49):119-22. PubMed ID: 155220
    [Abstract] [Full Text] [Related]

  • 19. Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function.
    Bean MA, Schellhammer PS, Herr HW, Pinsky CM, Whitmore WF.
    Natl Cancer Inst Monogr; 1978 Dec 20; (49):111-4. PubMed ID: 155219
    [Abstract] [Full Text] [Related]

  • 20. Skin tests with soluble tumor membrane antigens in patients with transitional cell cancers.
    Hollinshead AC.
    Natl Cancer Inst Monogr; 1978 Dec 20; (49):255-6. PubMed ID: 748779
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.